APO-SUMATRIPTAN
APOTEX INC
Quick answers
Is there a shortage of APO-SUMATRIPTAN in Canada?
No. There is no current shortage of APO-SUMATRIPTAN 50MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
IMITREX - TAB 50MG
GLAXO CANADA INC
DOM-SUMATRIPTAN
DOMINION PHARMACAL
AVA-SUMATRIPTAN
AVANSTRA INC
NU-SUMATRIPTAN
NU-PHARM INC
SANDOZ SUMATRIPTAN
SANDOZ CANADA INCORPORATED
Other Products
IMITREX TAB 100MG
GLAXO CANADA INC
DIN
02268388
Strength
50MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
SUMATRIPTAN (SUMATRIPTAN SUCCINATE)
See all SUMATRIPTAN (SUMATRIPTAN SUCCINATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178